1 in 4 people die
“I’m very excited about the MyoVista”
Introducing Myovista – new, low cost technology to assist in screening for heart disease.
Myovista at a Glance
Easy to perform – Easy to interpret
Follows standard 12 lead ECG protocol
Produces both conventional ECG tracing and enhanced MyoVista reporting
Low cost test – Equivalent per test cost to ECG
Non-invasive – Safe with no risk
15 minute test with immediate results
Comprehensive detailed report – Advanced screening capabilities
Assists in early screening assessment for a wide range of heart diseases.
Reimbursement by insurance
Available early 2016